CPX-351 plus gemtuzumab ozogamicin in relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome

Blood Neoplasia · Elsevier

Аннотация

Publication date: November 2026 Source: Blood Neoplasia, Volume 3, Issue 4 Author(s): Yesid Alvarado, Jayastu Senapati, Tapan M. Kadia, Gautam Borthakur, Guillermo Montalban-Bravo, Nicholas J. Short, Naval Daver, Courtney D. DiNardo, Lucia Masarova, Alessandra Ferrajoli, Fadi G. Haddad, Elias Jabbour, Alex Bataller Torralba, Sheila Tan, Sankalp Arora, Sherry Pierce, Stefan Faderl, Guillermo Garcia-Manero, Hagop M. Kantarjian, Farhad Ravandi

Читать у издателя →

Похожие статьи